Peripheral-type benzodiazepine receptors in human prostate

Area of Science:

• Pharmacology
• Urology
• Neuroscience

Background:

• Peripheral benzodiazepine receptors (PBPRs) are implicated in various physiological and pathological processes.
• Their presence and role in the human prostate, particularly in conditions like benign prostatic hyperplasia (BPH), require further elucidation.

Purpose of the Study:

• To investigate the presence and characteristics of PBPRs in normal human prostate tissue and prostatic nodular hyperplasia.
• To determine if the density of PBPRs changes in the context of BPH.

Main Methods:

• Radioligand binding assays were performed on human prostate tissue samples (normal and hyperplastic).
• Two specific radioligands, [3H]Ro 5-4864 and [3H]PK 11195, were used to quantify PBPR binding.
• Scatchard analysis was employed to determine binding site density (Bmax) and affinity (KD).

Main Results:

• Peripheral benzodiazepine receptors were successfully identified in both normal and hyperplastic human prostate tissues.
• Binding of both radioligands ([3H]Ro 5-4864 and [3H]PK 11195) was saturable, indicating specific binding.
• [3H]PK 11195 demonstrated higher affinity for PBPRs compared to [3H]Ro 5-4864.
• No significant difference in the density (Bmax) of PBPRs was observed between normal prostate tissue and prostatic nodular hyperplasia.

Conclusions:

• Peripheral benzodiazepine receptors are present in the human prostate.
• Prostatic nodular hyperplasia is not associated with alterations in the density of these receptors.
• These findings contribute to understanding the role of PBPRs in prostate physiology and pathology.